Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...
Primary endpoints of both Advance-HTN and Launch-HTN studies, using lorundrostat to treat patients with hypertension were met ...
NDA submission based on results from Phase 3 DUPLEX and Phase 2 DUET studies of FILSPARI in FSGSIf approved, FILSPARI could become the first and ...
Background Effective management of coexisting heart failure (HF), chronic kidney disease (CKD) and type 2 diabetes mellitus ...
Other common symptoms include swelling in parts of the body, known as edema, as well as low blood albumin levels ... FILSPARI with angiotensin receptor blockers (ARBs), ERAs, or aliskiren.
NDA submission based on results from Phase 3 DUPLEX and Phase 2 DUET studies of FILSPARI in FSGS If approved, FILSPARI could become the first and only FDA-approved treatment for FSGS, a rare kidney ...
Other common symptoms include swelling in parts of the body, known as edema, as well as low blood albumin levels ... FILSPARI with angiotensin receptor blockers (ARBs), ERAs, or aliskiren.
So as we haven’t seen creatinine increases or high or albumin decreases ... start patients prophylactically on an ACE or an ARB unless they have a contraindication. But then the second big ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback